Site Home   Gender and Cardiovascular Disease       Introduction to Gender and Health   The Gender Lens Tool

According to Lisabeth et al.[1] there are no differences in the use of antithrombotics at discharge by race or sex and no differences in the prescribing of aspirin, warfarin, aspirin/extended release dipyridamole, or clopidogrel by race or sex after adjustment for confounders[1].

Another study, by Holroyd-Leduc et al. [3]found that elderly men are more likely than elderly women to receive aspirin and ticlopidine and equally like to receive warfarin after a stroke. Despite these differences, elderly women have a better 1-year survival after a stroke.

There are no gender-related differences in patients admitted with acute strokes, according to Sharma et al. The minor trend for higher acute-phase mortality in females is probably due to their less frequent lacunar strokes and less frequent use of aspirin prior to stroke. Men and women with acute strokes should have access to similar services[2].


1. Lisabeth, L., D., Roychoudhury, C., Brown, D., L., Levine, S., R., Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA ?, Neurology, 62: 2313-2315, 2004

2. Sharma JC, Fletcher S, Vassallo M, Characteristics and mortality of acute stroke patients: are there any gender differences? J Gend Specif Med. 2002 May-Jun;5(3):24-7

3. Holroyd-Leduc J, et al. Sex Differences and similarities in the Management and Outcome of Stroke Patients. Stroke. 2000; 31: 1833-37

All references for this section